| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT05076617 A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants… |
Trial sites reduced: 140 -> 137 locations |
| 2026-08-13 | NCT04225871 Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis |
Trial completed |
| 2026-08-12 | NCT07720375 A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… |
Recruitment opened |
| 2026-08-12 | NCT07720375 A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… |
Trial sites expanded: 0 -> 3 locations |
| 2026-08-08 | NCT04976322 A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study… |
Trial sites expanded: 118 -> 121 locations |
| 2026-08-08 | NCT06425549 A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in… |
Enrollment closed, study ongoing |
| 2026-08-08 | NCT06425549 A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in… |
Trial sites reduced: 50 -> 42 locations |
| 2026-08-08 | NCT06617325 A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants… |
Trial sites expanded: 233 -> 236 locations |
| 2026-08-04 | NCT07725939 A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… |
Recruitment opened |
| 2026-08-01 | NCT05076617 A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants… |
Trial sites reduced: 146 -> 140 locations |
| 2026-08-01 | NCT06921850 A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and… |
Enrollment closed, study ongoing |
| 2026-08-01 | NCT05077904 A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… |
date change Primary completion pushed: 2026-07-31 -> 2026-08-31 |
| 2026-08-01 | NCT05077904 A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… |
date change Completion pushed: 2026-07-31 -> 2026-08-31 |
| 2026-08-01 | NCT06149559 A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe… |
Enrollment increased: 12 -> 14 participants |
| 2026-08-01 | NCT04123795 A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol… |
Trial completed |
| 2026-07-25 | NCT07531511 SLC6A1-NDD Prospective Longitudinal Natural History Study |
Recruitment opened |
| 2026-07-25 | NCT07531511 SLC6A1-NDD Prospective Longitudinal Natural History Study |
Trial sites expanded: 0 -> 3 locations |
| 2026-07-25 | NCT04976322 A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study… |
Trial sites expanded: 113 -> 118 locations |
| 2026-07-24 | NCT04666610 A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy… |
Trial completed |
| 2026-07-24 | NCT04666610 A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy… |
date change Primary completion moved earlier: 2026-08-24 -> 2026-07-07 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-24 | NCT07725939 A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… | Phase 2 | Recruiting |
| 2026-07-22 | NCT07720375 A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07246564 | Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese… | Myasthenia Gravis | Recruiting |
| Phase 3 | |||
| NCT07463521 | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… | Ocular Myasthenia Gravis | Recruiting |
| NCT06668181 | An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in… | Enthesitis-related Arthritis | Recruiting |
| NCT07219420 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With… | Palmoplantar Pustulosis | Recruiting |
| NCT04715646 | A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents… | Epilepsy | Recruiting |
| NCT06617325 | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants… | Systemic Lupus Erythematosus | Recruiting |
| NCT05077904 | A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12… | Stereotypical Prolonged Seizures | Recruiting |
| NCT07465289 | A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult… | Ocular Myasthenia Gravis | Not Yet Recruiting |
| NCT06506916 | A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study… | Moderate to Severe Plaque Psoriasis | Active, Not Recruiting |
| NCT04901195 | A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT06435312 | An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| NCT06921850 | A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT04976322 | A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study… | Systemic Lupus Erythematosus | Enrolling by Invitation |
| NCT04436640 | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in… | Axial Spondyloarthritis | Active, Not Recruiting |
| NCT05063162 | A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With… | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) | Active, Not Recruiting |
| NCT05076617 | A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants… | Stereotypical Prolonged Seizures | Enrolling by Invitation |
| NCT06315322 | A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study… | Childhood Absence Epilepsy | Active, Not Recruiting |
| NCT06425549 | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in… | Moderate to Severe Plaque Psoriasis | Active, Not Recruiting |
| NCT06540144 | An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| Phase 2/3 | |||
| NCT06055959 | A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized… | Generalized Myasthenia Gravis | Recruiting |
| NCT06149559 | A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe… | Generalized Myasthenia Gravis | Active, Not Recruiting |
| Phase 2 | |||
| NCT07725939 | A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… | Chronic Obstructive Pulmonary Disease With Chronic Bronchitis | Recruiting |
| NCT07720375 | A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in… | Non-cystic Fibrosis Bronchiectasis | Recruiting |
| NCT07277660 | A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and… | Atopic Dermatitis | Recruiting |
| Phase 1 | |||
| NCT06961747 | A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women | Healthy Participants | Recruiting |